Clinical trial NCT03154268: Retrospective Longitudinal Study of Gestational Weight Gain Among Chinese Pregnant Women
Official title: Retrospective Longitudinal Study of Gestational Weight Gain Among Chinese Pregnant Women
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Gestational Weight Gain
Keywords: Gestational weight gain
Chinese pregnant women
Retrospective longitudinal study
China
IOM guideline
Adverse outcome
Model
Lead sponsor: West China Hospital
Sponsor class: OTHER
Collaborators: name: West China Second University Hospital
First posted: 2017-05-16
Enrollment: 10422
Sex: FEMALE
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: RETROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Chinese pregnant women who had deliveries at West China Women and Children's Hospital, Sichuan University

Brief summary: The purpose of this study is to investigate the reference ranges and rates of gestational weight gain among Chinese pregnant women, and to analyze the correlation between gestational weight gain and adverse outcomes.


Eligibility criteria: Inclusion Criteria:

1. Deliveries between January 2013 and December 2014;
2. Gestational age between 37 weeks or older and less than 42 weeks;
3. Registration with care documents at the first prenatal visit prior to the 15th gestational week;
4. Had at least five follow-up visits until delivery.

Exclusion Criteria: None

Primary outcomes:
measure: Preeclampsia
timeFrame: After 20th gestational weeks till delivery, about 5 months
measure: Eclampsia
timeFrame: After 20th gestational weeks till delivery, about 5 months
measure: ICP
timeFrame: After 14th gestational weeks till delivery, about 6 months
measure: Placenta previa
timeFrame: During pregnancy till delivery
measure: Gestational diabetes
timeFrame: After 24th gestational weeks, about 4 months
measure: Ruptured uterus
timeFrame: During delivery
measure: Placental abruption
timeFrame: After 20th gestational weeks till delivery, about 5 months
measure: Postpartum hemorrhage
timeFrame: Within 24h after delivery
measure: Hepatic diseases
timeFrame: During pregnancy, delivery or within 42 days of pregnancy termination, an average of 1 year
measure: Hematological diseases
timeFrame: During pregnancy, delivery or within 42 days of pregnancy termination, an average of 1 year
measure: Gynecological diseases
timeFrame: During pregnancy, delivery or within 42 days of pregnancy termination, an average of 1 year
measure: Respiratory diseases
timeFrame: During pregnancy, delivery or within 42 days of pregnancy termination, an average of 1 year
measure: Thyroid disease
timeFrame: During pregnancy, delivery or within 42 days of pregnancy termination, an average of 1 year
measure: ICU admission
timeFrame: During pregnancy, delivery or within 42 days of pregnancy termination, an average of 1 year
measure: Maternal death
timeFrame: During pregnancy, delivery or within 42 days of pregnancy termination, an average of 1 year
measure: Macrosomia
timeFrame: within 1 month after delivery
measure: Infant of low-birth weight
timeFrame: within 1 month after delivery
measure: Neonatal ICU admission
timeFrame: Within 1 month after delivery
measure: Neonatal death
timeFrame: Within 1 month after delivery
measure: Large for gestational age
timeFrame: Within 1 month after delivery
measure: Small for gestational age
timeFrame: Within 1 month after delivery
measure: Neonatal defect
timeFrame: Within 1 month after delivery
measure: Maternal adverse outcomes
timeFrame: During pregnancy, delivery or within 42 days of pregnancy termination, an average of 1 year
measure: Neonatal adverse outcomes
timeFrame: Within 1 month after delivery
Secondary outcomes:
Other outcomes:
Locations:
Study officials:
affiliation: Chinese Evidence-based Medicine Center, West China Hospital, Sichuan University
name: Xin Sun, Doctor
role: PRINCIPAL_INVESTIGATOR
References: